Washburn Theodore James Jr.

Principal Accounting OfficerAGIOS PHARMACEUTICALS, INC. (AGIO) · full profile →Form 4 · filed Mar 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$152K
Net Open-Market Flow
-$152K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Sell(S)5K$28.88$152K868

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001439222-26-000046) within minutes of acceptance. Every field above traces to the original document. Verify it directly: